Yokohama, Japan

Norio Funayama


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Norio Funayama: Innovator in Pharmaceutical Compounds

Introduction

Norio Funayama is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for medical applications. With a total of 2 patents to his name, Funayama's work focuses on innovative solutions for respiratory diseases.

Latest Patents

Funayama's latest patents include the Pyrrolopyrazolopyrimidine compound and medicine comprising the same. This invention relates to compounds represented by a specific general formula, where R¹ represents an alkyl group, R² represents an amino group or alkyl group, and R³ represents various functional groups. These compounds are designed for the prevention and treatment of respiratory diseases, showcasing Funayama's commitment to addressing critical health issues.

Career Highlights

Norio Funayama is associated with Pola Chemical Industries, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and treatment of respiratory conditions through the development of new medicinal compounds.

Collaborations

Funayama has collaborated with notable coworkers such as Takayuki Namiki and Masayuki Yuasa. These partnerships have contributed to the successful development of his patented inventions and have fostered a collaborative environment for innovation.

Conclusion

Norio Funayama's contributions to the field of pharmaceuticals highlight his role as an inventor dedicated to improving health outcomes. His innovative compounds and collaborative efforts continue to make a significant impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…